573Wire StoriesDr. Andreas Amrein Joins Advanced Clinical to Lead Global Development and Expansion in APAC, Europe and Canada
CHICAGO–(BUSINESS WIRE)–Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey,...
- 759Wire Stories
Manufacturing AI Provider BISTelligence Inks Deal With Silicon Valley’s Edge Automation Leader, Adapdix
SEOUL, South Korea & PLEASANTON, Calif.–(BUSINESS WIRE)–BISTelligence, a leading supplier of manufacturing AI analytics solutions and services for high-tech and industrial manufacturers...
- 655Wire Stories
Newfold Digital Agrees to Acquire Deluxe’s Australia Web Hosting Operations
JACKSONVILLE, Fla. & MINNEAPOLIS–(BUSINESS WIRE)–Newfold Digital, a leading web and commerce technology company backed by Clearlake Capital Group, L.P. and Siris Capital...
- 726Wire Stories
Rocket Lab Begins Qualification of Highest Performing Space Solar Cell Technology
Developed by SolAero Technologies Inc., a space solar power company recently acquired by Rocket Lab, the IMM-? solar cells are the highest...
- 577Wire Stories
Rocket Lab Begins Qualification of Highest Performing Space Solar Cell Technology
Developed by SolAero Technologies Inc., a space solar power company recently acquired by Rocket Lab, the IMM-? solar cells are the highest...
- 616Wire Stories
Alvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing U.S. Rights for Alvotech’s Proposed High-Concentration Biosimilar (AVT02) for Humira®
Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023 All ongoing U.S. disputes...
- 615Wire Stories
Northern Trust Asset Management Creates Asia-Pacific Based Team of Quantitative Specialists
Melbourne-based Scott Bennett Named to Lead Team MELBOURNE, Australia & HONG KONG–(BUSINESS WIRE)–Northern Trust Asset Management, one of the world’s leading investment...
- 602Wire Stories
Orum Therapeutics to Present Preclinical Data for ORM-5029, a Novel Antibody Neodegrader Conjugate, at the AACR Annual Meeting 2022
BOSTON & DAEJEON, South Korea–(BUSINESS WIRE)–#AACR22–Orum Therapeutics, a biotechnology company pioneering the development of tumor-directed targeted protein degraders, today announced that the...
- 564Wire Stories
Universal Display Corporation Announces Participation at Upcoming Conferences
EWING, N.J.–(BUSINESS WIRE)–$OLED #OLED—Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced its...
- 556Wire Stories
Megaport Appoints IT Industry Veteran Jim Brinksma to the Executive Team as Chief Technology Officer
Jim Brinksma joins Megaport as Chief Technology Officer after senior IT leadership roles at Ciena BluePlanet, Goldman Sachs, and InnovoEdge BRISBANE, Australia–(BUSINESS...
